Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

1 ArticlesStephen Evans-Frek

1 / 1

Sun Pharma Acquires Ocular Technologies and Launches Authorized Generic (AG) Versions of 4 Tablets

Sun Pharma – the world’s fifth largest specialty generic pharmaceutical company and India’s top pharmaceutical company providing medicines to ...

Oct 27, 2016

Sun-Pharma-Share-Price-27-October-2016.png

Sign up for Newsletters

Get a roundup of our exclusive insights on markets and investing delivered to your inbox at your preferred frequency.

Join Capitalmind Premium

Starts at ₹1,499/mo

Get access to our equity, fixed income, macro and personal finance research, model equity and fixed-income portfolios, exclusive apps, tutorials, and member community.